Tenax Therapeutics (TENX) Other Non-Current Assets (2011 - 2024)
Tenax Therapeutics recorded quarterly Other Non-Current Assets of $1117.0 in Q3 2024, little changed quarter-over-quarter from $1117.0 in Q2 2024, and little changed year-over-year from $1117.0 in Q4 2023.
Tenax Therapeutics' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $1117.0 for Q3 2024.
- In Q3 2024, Other Non-Current Assets changed 0.0% year-over-year to $1117.0; the TTM figure through Sep 2024 stood at $1117.0 (changed 0.0% YoY), while the FY2023 annual figure was $1000.0, down 89.53% from the prior year.
- Other Non-Current Assets came in at $1117.0 for Q3 2024 at Tenax Therapeutics, roughly flat from $1117.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $9552.0 in Q4 2022 to a low of $1000.0 in Q4 2023.
- A 5-year average of $5791.5 and a median of $8435.0 in 2020 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets climbed 13.24% in 2022 and tumbled 89.53% in 2023, its largest moves.
- Tenax Therapeutics' Other Non-Current Assets stood at $8435.0 in 2020, then changed by 0.0% to $8435.0 in 2021, then advanced by 13.24% to $9552.0 in 2022, then sank by 89.53% to $1000.0 in 2023, then grew by 11.7% to $1117.0 in 2024.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $1117.0, $1117.0, and $1117.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1,117.00 |
| Jun 30, 2024 | 1,117.00 |
| Mar 31, 2024 | 1,117.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,117.00 |
| Jun 30, 2023 | 1,117.00 |
| Mar 31, 2023 | 1,117.00 |
| Dec 31, 2022 | 9,552.00 |
| Sep 30, 2022 | 8,435.00 |
| Jun 30, 2022 | 8,435.00 |
| Mar 31, 2022 | 8,435.00 |
| Dec 31, 2021 | 8,435.00 |
| Sep 30, 2021 | 8,435.00 |
| Jun 30, 2021 | 8,435.00 |
| Mar 31, 2021 | 8,435.00 |
| Dec 31, 2020 | 8,435.00 |
| Sep 30, 2020 | 8,435.00 |
| Jun 30, 2020 | 8,435.00 |
| Mar 31, 2020 | 8,435.00 |
| Dec 31, 2019 | 8,435.00 |
| Sep 30, 2019 | 8,435.00 |
| Jun 30, 2019 | 8,435.00 |
| Mar 31, 2019 | 8,435.00 |
| Dec 31, 2018 | 8,435.00 |
| Sep 30, 2018 | 8,435.00 |
| Jun 30, 2018 | 8,435.00 |
| Mar 31, 2018 | 8,435.00 |
| Dec 31, 2017 | 8,435.00 |
| Sep 30, 2017 | 2,762.00 |
| Jun 30, 2017 | 1.11 Mn |
| Mar 31, 2017 | 1.11 Mn |
| Dec 31, 2016 | 1.11 Mn |
| Sep 30, 2016 | 1.11 Mn |
| Jun 30, 2016 | 1.11 Mn |
| Dec 31, 2015 | 1.11 Mn |
| Apr 30, 2013 | 58,262.00 |
| Jan 31, 2013 | 58,262.00 |
| Oct 31, 2012 | 58,262.00 |
| Jul 31, 2012 | 65,666.00 |
| Apr 30, 2012 | 65,666.00 |
| Jan 31, 2012 | 65,666.00 |
| Oct 31, 2011 | 149,652.00 |
| Jul 31, 2011 | 161,512.00 |
| Apr 30, 2011 | 147,608.00 |